An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
Clinical trial NCT00904826 · COMPLETED
Trial details
- NCT number
- NCT00904826
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2011-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.